Shanghai Henlius Biotech shares soar in Hong Kong after Fosun’s US$690 million buyout offer
China International Capital Corp (CICC) and Fosun International Capital, a subsidiary of Fosun International, are joint financial advisers for the deal. “The listing status of the company no longer provides …